Neuromuscular interaction of sevoflurane cisatracurium in a myasthenic patient

被引:6
作者
Baraka, AS [1 ]
Taha, SK [1 ]
Kawkabani, NI [1 ]
机构
[1] Amer Univ Beirut, Dept Anesthesiol, Beirut, Lebanon
来源
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE | 2000年 / 47卷 / 06期
关键词
D O I
10.1007/BF03018948
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose: To describe the influence of sevoflurane anesthesia on cisatracurium neuromuscular block in a myasthenic patient undergoing thymectomy. Clinical features: A myasthenic patient (Osserman IIB) was managed for one year before surgery with 60 mg pyridostigmine qid, 50 mg immuran tid and 30 mg prednisone therapy. Pyridostigmine was interrupted three months before surgery, and five sessions of plasmapheresis were done within 13 days before surgery, The neuromuscular response was monitored by Datex electromyographic response to train-of-four stimulation of the ulnar nerve. Sevoflurane 4% decreased the T-1/C ratio by 20%. Administration of 0.025 mg.kg(-1) cisatracurium, during sevoflurane anesthesia, was followed by complete neuromuscular block for 45 min, Discontinuation of sevoflurane resulted, after 10 min, in recovery of the T-1 which reached T-1/C ratio of 50% after 30 min. Conclusion: The marked sensitivity of this myasthenic patient to 0.5 x ED95 of cisatracurium can be attributed to potentiation of cisatracurium neuromuscular block by sevoflurane, as evidenced by the reappearance of the first twitch of the train-of-four response 10 min after sevoflurane was discontinued.
引用
收藏
页码:562 / 565
页数:4
相关论文
共 13 条
[1]   Sevoflurane exposure time and the neuromuscular blocking effect of vecuronium [J].
Ahmed, AAK ;
Kumagai, M ;
Otake, T ;
Kurata, Y ;
Amaki, Y .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1999, 46 (05) :429-432
[2]   ANESTHESIA AND MYASTHENIA-GRAVIS [J].
BARAKA, A .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1992, 39 (05) :476-486
[3]   Cisatracurium in a myasthenic patient undergoing thymectomy [J].
Baraka, A ;
Siddik, S ;
Kawkabani, N .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1999, 46 (08) :779-782
[4]   THE CLINICAL NEUROMUSCULAR PHARMACOLOGY OF 51W89 IN PATIENTS WITH RECEIVING NITROUS-OXIDE OPIOID BARBITURATE ANESTHESIA [J].
BELMONT, MR ;
LIEN, CA ;
QUESSY, S ;
ABOUDONIA, MM ;
ABALOS, A ;
EPPICH, L ;
SAVARESE, JJ .
ANESTHESIOLOGY, 1995, 82 (05) :1139-1145
[5]   ELECTROPHYSIOLOGICAL INVESTIGATION OF NEURO-MUSCULAR TRANSMISSION IN MYASTHENIA GRAVIS [J].
ELMQVIST, D ;
KUGELBERG, J ;
HOFMANN, WW ;
QUASTEL, DMJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1964, 174 (03) :417-&
[6]   CHARACTERISTICS AND MECHANISM OF NEUROMUSCULAR BLOCK IN MYASTHENIA-GRAVIS [J].
GROB, D ;
NAMBA, T .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 274 (MAY28) :143-173
[7]   EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS AND MYASTHENIA-GRAVIS - BIOCHEMICAL AND IMMUNOCHEMICAL ASPECTS [J].
LINDSTROM, JM ;
LENNON, VA ;
SEYBOLD, ME ;
WHITTINGHAM, S .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 274 (MAY28) :254-274
[8]   INADEQUATE ANTAGONISM OF VECURONIUM-INDUCED NEUROMUSCULAR BLOCK BY NEOSTIGMINE DURING SEVOFLURANE OR ISOFLURANE ANESTHESIA [J].
MORITA, T ;
TSUKAGOSHI, H ;
SUGAYA, T ;
SAITO, S ;
SATO, H ;
FUJITA, T .
ANESTHESIA AND ANALGESIA, 1995, 80 (06) :1175-1180
[9]   HALOTHANE-INDUCED VARIABILITY IN THE NEUROMUSCULAR-TRANSMISSION OF PATIENTS WITH MYASTHENIA-GRAVIS [J].
NILSSON, E ;
PALOHEIMO, M ;
MULLER, K ;
HEINONEN, J .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1989, 33 (05) :395-401
[10]   NEUROMUSCULAR EFFECTS OF ISOFLURANE IN PATIENTS WITH MYASTHENIA-GRAVIS [J].
NILSSON, E ;
MULLER, K .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1990, 34 (02) :126-131